Boardroom Radio - Straight from the source

Australia's Largest Corporate Webcaster

"Boardroom Radio brings companies to my desk. I can hear more investor briefings. Also the calendar is very useful" Matt Williams, Portfolio Manager, Perpetual

"IRESS is always seeking innovative ways to deliver relevant content to our professional user base. Webcasting is a growing and increasingly important way to communicate and we are very pleased to team with Boardroom Radio to further expand our company disclosure information." Peter Dunai, Managing Director, IRESS

"As the investment world continues to become more virtual and the reaction to the release of new investment information becomes faster, Boardroom Radio offers an easy way for all investors to access the latest information for companies." Peter Morgan, Founder 452 Capital

"Boardroom Radio will be a valuable tool to help us manage our time and connect with companies whose stories we wouldn’t normally hear" Ben Griffiths, Eley Griffiths Group

"The service from Boardroom Radio has been outstanding. To hear that we had so many listeners confirmed that Boardroom Radio is an effective communication tool." Roc Oil (ROC)

"Macquarie Airports is happy to trial new and innovative ways of increasing communication to our investors. Boardroom Radio is a particularly easy and flexible method of informing all our stakeholders of MAp's activities." Macquarie Airports (MAP)

"Boardroom Radio provides a modern, highly effective means of communicating Bonaparte's key developments to its shareholders and to a broader spectrum of the investing community in a concise and personal way." Bonaparte Diamond Mines NL

ANTISENSE THERAPEUTICS LIMITED (ANP)

ASX code: ANP
Listing Date: Thu, 20 Dec 2001
Website: http://www.antisense.com.au/
Industry: Pharmaceuticals, Biotechnology & Life Sciences

Principal Activities:
The development of novel antisense pharmaceuticals for commercially important human conditions.

Address:
, 10 Wallace Avenue, Level 1,
TOORAK
VIC 3142

Phone: (03) 9827 8999
Fax: (03) 9827 1166

Executives & Directors

Mr Robert Moses, Chairman
Mr Mark Diamond, Managing Director, CEO
Mr Chris Belyea, Non Exec. Director
Prof. Graham Mitchell, Non Exec. Director
Prof. George Werther, Non Exec. Director
Mr Phillip Hains, CFO
Mr Simon Watkin, Investor Relations
Mr Phillip Hains, Company Secretary
Ms Kate Plumridge, Joint Co. Secretary

Please contact the ASX to change these details

Company Podcasts

Subscribe to current and future audio events for ANP

Company ASX Announcements

Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.

View this company's details on the Australian Securities Exchange website

ANTISENSE THERAPEUTICS LIMITED (ANP) Events

Company (Stock Code)	Date/Time	Event
ANTISENSE THERAPEUTICS LIMITED (ANP)	Thu, 29 Jun 2006 02:00PM	ANP - Commencement of Phase IIa Multiple Sclerosis Trial - Mr Mark Diamond, CEO
ANTISENSE THERAPEUTICS LIMITED (ANP)	Wed, 4 Feb 2009 11:00PM	Interim Results
ANTISENSE THERAPEUTICS LIMITED (ANP)	Fri, 31 Oct 2008 09:00AM	Annual General Meeting Minter Ellison Lawyers, Rialto Towers, 525 Collins St, Melbourne, VIC
ANTISENSE THERAPEUTICS LIMITED (ANP)	Wed, 13 Aug 2008	Full Year Results
ANTISENSE THERAPEUTICS LIMITED (ANP)	Sun, 3 Feb 2008 11:00PM	Interim Results
ANTISENSE THERAPEUTICS LIMITED (ANP)	Wed, 21 Nov 2007 09:00AM	Annual General Meeting Computershare Conference Centre, 452 Johnston Street Abbotsford Victoria
ANTISENSE THERAPEUTICS LIMITED (ANP)	Wed, 28 Mar 2007	EGM
ANTISENSE THERAPEUTICS LIMITED (ANP)	Mon, 29 Jan 2007 11:00PM	Interim Results
ANTISENSE THERAPEUTICS LIMITED (ANP)	Tue, 10 Oct 2006 11:00AM	Annual General Meeting Computershare Conference Centre, Yarra Falls, 452 Johnston Street Abbotsford VIC 3067
ANTISENSE THERAPEUTICS LIMITED (ANP)	Mon, 7 Aug 2006	Full Year Results
ANTISENSE THERAPEUTICS LIMITED (ANP)	Thu, 16 Feb 2006 11:00PM	Interim Results
ANTISENSE THERAPEUTICS LIMITED (ANP)	Thu, 20 Oct 2005	Annual General Meeting
		Display

ANTISENSE THERAPEUTICS LIMITED (ANP)

Click here to view details on the ASX site

ANP completes ATL/TV1102 Phase IIa Clinical Study Report	Fri, 26 Jun 2009
ATL1101 enhances chemotherapy anti-tumour effect	Thu, 18 Jun 2009
ANP to present to Isis Shareholders in the US	Mon, 1 Jun 2009
Change of Director`s Interest Notice - RM	Fri, 22 May 2009
Market Update	Thu, 21 May 2009
ATL/TV1102 Phase IIa data presented at AAN Annual Meeting	Thu, 30 Apr 2009
Appendix 4C - Quarterly Cashflow Report	Thu, 16 Apr 2009
Change of Director`s Interest Notice - MD	Thu, 9 Apr 2009
Investment Overview Presentation	Tue, 7 Apr 2009
Appendix 3Y - BM	Fri, 3 Apr 2009

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.